Related references
Note: Only part of the references are listed.CCR4+ monocytic myeloid-derived suppressor cells are associated with the increased epithelial-mesenchymal transition in pancreatic adenocarcinoma patients
Vinit Sharma et al.
IMMUNOBIOLOGY (2022)
Myeloid-Derived Suppressor Cells as Key Players and Promising Therapy Targets in Prostate Cancer
Izabela Sieminska et al.
FRONTIERS IN ONCOLOGY (2022)
Myeloid derived suppressor cells and innate immune system interaction in tumor microenvironment
Anik Pramanik et al.
LIFE SCIENCES (2022)
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide
Ayman J. Oweida et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy
Rebekka Weber et al.
CELLULAR IMMUNOLOGY (2021)
IL-6 is associated with expansion of myeloid-derived suppressor cells and enhanced immunosuppression in pancreatic adenocarcinoma patients
Vinit Sharma et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression
Zhengze Lu et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2021)
MDSC: Markers, development, states, and unaddressed complexity
Samarth Hegde et al.
IMMUNITY (2021)
Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors
Alison P. Klein
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Epithelial-mesenchymal transition: When tumor cells meet myeloid-derived suppressor cells
Jingshan Cai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)
Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
Yue Qiu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Risk factors of pancreatic cancer and their possible uses in diagnostics
Jitka LANG et al.
NEOPLASMA (2021)
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
Naoki Horikawa et al.
BRITISH JOURNAL OF CANCER (2020)
Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer
Shipra Das et al.
CANCER RESEARCH (2020)
Myeloid-derived suppressor cells-new and exciting players in lung cancer
Zhenzhen Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Jia-qiao Fan et al.
MOLECULAR CANCER (2020)
Combined blockade of TGf-β1 and GM-CSF improves chemotherapeutic effects for pancreatic cancer by modulating tumor microenvironment
Qiaofei Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Chiara Porta et al.
CANCER RESEARCH (2020)
Pexidartinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor: safety and efficacy
Emanuela Palmerini et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non-Small Cell Lung Cancer
Elodie Lauret Marie Joseph et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Pancreatic cancer treatment: better, but a long way to go
Robert J. Torphy et al.
SURGERY TODAY (2020)
Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer
Ece Tavukcuoglu et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model
Philipp Metzger et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Immunotherapy for pancreatic cancer: A 2020 update
Dimitrios Schizas et al.
CANCER TREATMENT REVIEWS (2020)
Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
Congcong Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance
Leila Akkari et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma
Emilien Loeuillard et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Regulation and modulation of antitumor immunity in pancreatic cancer
Joshua Leinwand et al.
NATURE IMMUNOLOGY (2020)
Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer
Xuguang Yang et al.
CANCER IMMUNOLOGY RESEARCH (2020)
High M-MDSC Percentage as a Negative Prognostic Factor in Chronic Lymphocytic Leukaemia
Michal Zarobkiewicz et al.
CANCERS (2020)
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Leonard Kaps et al.
CELLS (2020)
Quantitative Tyrosine Phosphoproteomic Analysis of Resistance to Radiotherapy in Nasopharyngeal Carcinoma Cells
Lin Shen et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Murine- and Human-Derived Autologous Organoid/Immune Cell Co-Cultures as Pre-Clinical Models of Pancreatic Ductal Adenocarcinoma
Loryn Holokai et al.
CANCERS (2020)
Apigenin Increases SHIP-1 Expression, Promotes Tumoricidal Macrophages and Anti-Tumor Immune Responses in Murine Pancreatic Cancer
Krystal Villalobos-Ayala et al.
CANCERS (2020)
Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy
Zhongnan Yin et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Cytokines in the Treatment of Cancer
Kevin C. Conlon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
Luca Cassetta et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Inflammation and Pancreatic Cancer: Focus on Metabolism, Cytokines, and Immunity
Andrea Padoan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Chemotherapy for pancreatic cancer
Christoph Springfeld et al.
PRESSE MEDICALE (2019)
GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation
Michael Dougan et al.
IMMUNITY (2019)
RAS in pancreatic cancer
Simone Lanfredini et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Targeting the tumor microenvironment in pancreatic ductal adenocarcinoma
Veethika Pandey et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
Rebecka Hellsten et al.
PROSTATE (2019)
Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
Mathieu Grapin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Chemoresistance in Pancreatic Cancer
Siyuan Zeng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
Xinyu Tian et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
Gemcitabine nanoparticles promote antitumor immunity against melanoma
Yuan Zhang et al.
BIOMATERIALS (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease
Mi-Young Park et al.
FRONTIERS IN IMMUNOLOGY (2019)
Macrophage polarity in cancer: A review
Masoud Najafi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment
Laurel B. Darragh et al.
FRONTIERS IN IMMUNOLOGY (2019)
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells
Dan Li et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
E. Versteijne et al.
BRITISH JOURNAL OF SURGERY (2018)
Targeting myeloid-derived suppressor cells for cancer immunotherapy
Yijun Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy
Raimund Bauer et al.
CANCER RESEARCH (2018)
Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer
Wei Li et al.
CELL METABOLISM (2018)
Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
Jie Lan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Challenges in diagnosis of pancreatic cancer
Lulu Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB
Po-Hao Feng et al.
Oncotarget (2018)
Phosphodiesterase-5 inhibition reduces postoperative metastatic disease by targeting surgery-induced myeloid derived suppressor cell-dependent inhibition of Natural Killer cell cytotoxicity
Lee-Hwa Tai et al.
ONCOIMMUNOLOGY (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Interleukin-1 Beta-A Friend or Foe in Malignancies?
Rebekka Bent et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Pancreatic cancer: challenges and opportunities
Huiyun Zhu et al.
BMC MEDICINE (2018)
Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes
Andrew McGuigan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Immunotherapy and Prevention of Pancreatic Cancer
Alexander H. Morrison et al.
TRENDS IN CANCER (2018)
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy
David Briere et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Management of functional neuroendocrine tumors of the pancreas
Kjell Oberg
GLAND SURGERY (2018)
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms
T. Kordbacheh et al.
ANNALS OF ONCOLOGY (2018)
Myeloid-derived suppressor cells and their role in pancreatic cancer
M. Pergamo et al.
CANCER GENE THERAPY (2017)
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
George A. Dominguez et al.
CLINICAL CANCER RESEARCH (2017)
Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
Yaqing Zhang et al.
GUT (2017)
Recent progress in GM-CSF-based cancer immunotherapy
Wan-Lun Yan et al.
IMMUNOTHERAPY (2017)
Recent Developments in Radiotherapy
Deborah E. Citrin
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang et al.
NATURE COMMUNICATIONS (2017)
Pro-inflammatory Signaling in a 3D Organotypic Skin Model after Low LET Irradiation-NF-κB, COX-2 Activation, and Impact on Cell Differentiation
Anna Acheva et al.
FRONTIERS IN IMMUNOLOGY (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors
Vinit Kumar et al.
CANCER CELL (2017)
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma
Ashley Orillion et al.
CLINICAL CANCER RESEARCH (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer
Zibing Wang et al.
ONCOTARGET (2016)
Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response
Paola Cappello et al.
ONCOIMMUNOLOGY (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
Surveying the serologic proteome in a tissue-specific kras(G12D) knockin mouse model of pancreatic cancer
Michael R. Ludwig et al.
PROTEOMICS (2016)
Epidemiology of pancreatic cancer
Milena Ilic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the accumulation and functional activity of myeloid-derived suppressor cells (MDSCs) in pancreatic cancer
Jinhoi Song et al.
ONCOTARGET (2016)
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity
Sabina Sangaletti et al.
CELL REPORTS (2016)
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma
Bruce D. Freimark et al.
CANCER IMMUNOLOGY RESEARCH (2016)
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer
Leonie Muehlberg et al.
ONCOIMMUNOLOGY (2016)
Myeloid-Derived Cells in Tumors: Effects of Radiation
Ralph E. Vatner et al.
SEMINARS IN RADIATION ONCOLOGY (2015)
Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells
Svetlana Karakhanova et al.
ONCOIMMUNOLOGY (2015)
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease
Joseph Markowitz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
Nicola E. Annels et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
Roheena Z. Panni et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Managing the Fruits of Our Success
Margaret Tempero
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
The Receptor for Advanced Glycation End Products Promotes Pancreatic Carcinogenesis and Accumulation of Myeloid-Derived Suppressor Cells
Philip J. Vernon et al.
JOURNAL OF IMMUNOLOGY (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
I. Poschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Harnessing γδ T cells in anticancer immunotherapy
Dalil Hannani et al.
TRENDS IN IMMUNOLOGY (2012)
Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Fas lpr mouse
Yasunori Iwata et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Share Paper
